Dennis Weaver, Chief Clinical Officer at Oscar Health, Inc. (OSCR), sold 1,548 shares at $4.69 ($7K) on 2022-06-02, disclosed to the SEC on 2022-06-03.
Scheduled sale ($7k) by Chief Clinical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| OSCR | SELL | 2022-03-03 | $13K | — | Filing → |
| OSCR | SELL | 2021-12-03 | $21K | — | Filing → |
| OSCR | SELL | 2021-09-02 | $104K | — | Filing → |